NCT03965637 is a Phase 3 clinical trial of vitamin C in Abdominal Hysterectomy, sponsored by Shahid Beheshti University.

Who is sponsoring NCT03965637?

NCT03965637 is sponsored by Shahid Beheshti University.

What drugs are being tested in NCT03965637?

Interventions in NCT03965637: vitamin C.

What condition does NCT03965637 study?

NCT03965637 studies Abdominal Hysterectomy.

Is NCT03965637 still recruiting?

NCT03965637 is currently completed. Last updated 4 May 2020.

Last reviewed 2020-05-04 · How we verify

NCT03965637

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Intravenous Ascorbic Acid Administration in Hysterectomy

Completed Phase 3 Last updated 4 May 2020

What this trial tests

Phase 3 trial testing vitamin C in Abdominal Hysterectomy in 80 participants. Completed in 30 January 2020.

Timeline

23 August 2019

Primary endpoint
30 January 2020

30 January 2020

Quick facts

Lead sponsor	Shahid Beheshti University
Phase	Phase 3
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	none
Primary purpose	prevention
Enrollment	80
Start date	23 August 2019
Primary completion	30 January 2020
Estimated completion	30 January 2020
Sites	1 location across Iran

Drugs / interventions tested

vitamin C — full drug profile →

Conditions studied

Abdominal Hysterectomy — all drugs for Abdominal Hysterectomy →

Sponsor

Shahid Beheshti University

Who can join

Adults 18 to 65, female only, with Abdominal Hysterectomy. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

vitamin C or ascorbic acid has known role in tissue repair. due to it's properties(water\_soluble), vitamin c is not stored in the body and when depleted, the bleeding tendency will increase due to dysfunctional connective tissues production in vessel wall and it has some important functions in platelets.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Effect of intravenous ascorbic acid administration on hemorrhage and wound complications in total abdominal hysterectomy: A prospective randomized clinical trial.
Farahani-Jam S, Yaghmaei M, Vahdat Shariatpanahi Z. · · 2022 · cited 3× · PMID 35623878 · DOI 10.1016/j.clnesp.2022.03.024

Verify or expand the search:

Other trials of vitamin C

Trials testing the same drug.

NCT06857734 — Analgesic and Anti-inflamatory Effect of Vit. B · NA · not yet recruiting
NCT06749756 — Study on the Improvement of Microcirculation in Patients With Sepsis by Vitamin B6, Vitamin B12 and Vitamin C · NA · recruiting
NCT03166787 — Hookah Smoking, Carbon Monoxide, and Coronary Endothelial Function · Phase 1 · terminated

Other recruiting trials for Abdominal Hysterectomy

Currently open trials in the same condition.

NCT06766994 — The Effect of Two Different Analgesic Techniques on Postoperative Recovery Quality · NA · recruiting
NCT06815393 — COMPARISON of the EFFECT of TWO DIFFERENT ANALGESIS TECHNIQUES in ABDOMINAL HYSTERECTOMY · NA · recruiting

Other Shahid Beheshti University trials

Trials by the same sponsor.

NCT06825377 — Comparing High-protein Vs. Standard Protein Nutritional Support in Critically Ill Patients At Risk for Refeeding Syndrom · NA · recruiting
NCT06483932 — Barberry and Cardiometabolic Risk Factors in Individuals With Hypertriglyceridemia · NA · completed
NCT06020950 — Chia Seeds Consumption in Hypertriglyceridemia · NA · completed
NCT05995002 — Anthocyanin Intake on Cardiometabolic Biomarkers · NA · completed
NCT05589350 — High-fat Yogurt and Plasma Lipids Profile · NA · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03965637 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Shahid Beheshti University
Last refreshed: 4 May 2020

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03965637.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing